ESC 365 - Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes

ESC Premium Access

Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes

Session: Late Breaking Science in Acute Coronary Syndromes 1

Topic: Lipid-Lowering Agents

Speaker: Doctor K. Koskinas (Bern, CH)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Konstantinos Koskinas

Bern University Hospital, Inselspital, Bern (Switzerland)

17 presentations

25 followers

3 more presentations in this session

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes: The Australian GRACE Risk score Intervention Study

Speaker: Professor D. Brieger (Concord, AU)

COMBinAtion Therapy with remote ischemic conditioning and exenatide in Myocardial Infarction. Primary results of The COMBAT-MI trial

Speaker: Doctor I. Otaegui Irurueta (Barcelona, ES)

Randomised comparison of clopidogrel versus ticagrelor or prasugrel in patients of 70 years or older with non-ST-elevation acute coronary syndrome - POPular AGE

Speaker: Miss M. Gimbel (Nieuwegein, NL)

Access the full session

Late Breaking Science in Acute Coronary Syndromes 1

Speakers: Doctor K. Koskinas, Professor D. Brieger, Doctor I. Otaegui Irurueta, Miss M. Gimbel

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources